The hyaluronan [HA] synthases catalyze the addition of two different monosaccharides from UDP-sugar substrates to the linear heteropolysaccharide chain. In order to accomplish this task, the HA synthases must be able to bind and to transfer from both UDP-sugar substrates. Until now, it has been impossible to distinguish between these two abilities. We have created a mutant of xlHAS1, a HA synthase from Xenopus laevis, that allows for the examination of the enzyme's ability to bind substrate only. The ability of different compounds to protect the xlHAS1(C337S) mutant enzyme from loss of activity due to treatment with N-ethylmaleimide, a cysteine modifying reagent, yields information on the relative affinity of a variety of nucleotides and nucleotide-sugars. We have observed that the substrate-binding selectivity is more relaxed than the specificity of catalytic transfer. The only attribute that appears to be absolutely required for binding is a nucleotide containing two phosphates complexed with magnesium ion. The role of certain cysteine residues in catalysis was also evaluated. C307 of xlHAS1 may play a role in catalysis or in maintaining structure. Mutation of C337 raises the UDP-GlcUA Michaelis constant (K m ), suggesting that this residue participates in UDP-GlcUA substrate binding or in catalytic complex formation.
INTRODUCTION

HA
1 is a glycosaminoglycan composed of alternating repeats of the disaccharide (→4)-β-DGlcUA(1→3)-β-D-GlcNAc(1→). This polysaccharide is abundant in vertebrates where it plays structural, recognition, and signaling roles (1) . The enzymes that catalyze the formation of HA, the HA synthases, are dual-action glycosyltransferases that catalyze the transfer of both GlcUA and GlcNAc (2, 3) . These membrane-associated enzymes utilize UDP-linked sugar precursors.
We have reported previously that xlHAS1 is highly specific for the authentic HA substrates, UDP-GlcUA and UDP-GlcNAc; the C4 epimers or UDP-glucose will not support HA biosynthesis (4) .
The vertebrate, the streptococcal, and the viral enzymes are comparable in size and have regions or short sequence elements with considerable similarity (2) . A few of these putative elements, for example the DXD-containing motif, are similar to other glycosyltransferases that produce various α-or β-linked polysaccharides from UDP-sugars (5-7). However, the exact role of these motifs in the structure and/or the function of the polypeptide are only recently being investigated. In view of the close amino acid sequence similarities among many glycosyltransferases, it is quite likely that these residues are involved in binding common determinants of UDP-sugars (e.g. uridine ring, phosphate groups) and/or catalyzing the transfer of sugars residues. 4 X-ray crystal structures have been obtained for several different glycosyltransferases from bacteria, a bacteriophage, and vertebrates that utilize UDP-sugars as well as for a bacterial UDPglucose dehydrogenase (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . All of these structures show extensive hydrophobic interactions with the uracil ring and hydrogen bonding with the functional groups of the uracil as well as with the ribose hydroxyls and phosphates (Table 1) . Many of these transferases use the DXD motif to coordinate the divalent metal cation and interact with the phosphate groups of UDP (5) (6) (7) (14) (15) (16) .
In lieu of a three-dimensional structure or active-site labeling data, the direct measurement or analysis of the binding of substrates to glycosyltransferases is often quite difficult or even impossible due to the low relative affinity of nucleotide-sugars for the enzymes. For example, the K m value of xlHAS1 for UDP-sugars ranges from ~100 µM to almost 1 mM, depending on experimental conditions (ref. 4 ; Table 2 ). Direct binding assays would require any washing steps removing unbound substrate to be completed in a few seconds time. Equilibrium dialysis experiments would require long times (which can be problematic for labile UDP-sugars) and yield relatively weak signals.
The situation is further complicated by the extreme difficulty in purifying the vertebrate HASs in a native state; most binding assessments should be performed on enriched or purified membrane preparations because many other nucleotide binding proteins exist. Therefore, we employed an indirect method, utilizing protection from inactivation mediated by a chemical modification agent, NEM, to assess the relative affinity of a vertebrate HAS for a wide range of compounds. These molecules have some or most of the structural elements of the authentic UDP-sugars for HA biosynthesis. Our assumption is that a compound interacting with the substrate-binding pocket or cleft will block NEM's access to the site and protect the enzyme from chemical modification and subsequent inactivation. We found that some structural 
EXPERIMENTAL PROCEDURES
Production of Recombinant xlHAS1 Wild Type and Cysteine Mutant Enzymes -All reagents
were from Sigma or Fisher unless noted otherwise. The construction and the use of the xlHAS1 expression plasmid for studies in yeast were previously described (4, 19) . Basically, the xlHAS1 polypeptide was cloned into the pYES2 vector (Invitrogen) under control of the GAL1 promoter to form pYES/DG+. Site-directed mutagenesis was performed on pYES/DG+ using the QuikChange Kit (Stratagene). Seven cysteine codons were altered using pairs of synthetic oligonucleotides containing either the partially degenerate codon (TYS, where Y = C or T; S = G or C) or the serine codon (TCT) to obtain a variety of mutants. Plasmids derived from independent transformants were sequenced to verify the presence of mutations at the various cysteine codons. The entire open reading frame of each mutant was also verified by sequencing.
The following mutants were generated: C117F, C117L, C117S, C210S, C239S, C298F, C298L, C298S, C304S, C307S, C337S, C239S/C337S, C304S/C337S, and C307S/C337S. Products Inc.) precursors as described previously (4, 19) . Briefly, crude membranes were incubated at 30°C in Tris buffer, pH 7.5, with MgCl 2 and the UDP-sugar precursors.
Unincorporated, labeled UDP-sugars were separated from the HA product using paper chromatography. HA at the origin of the paper strip was detected by liquid scintillation counting.
Assays were set so that <5% of the radiolabeled substrate was consumed and the enzyme concentration was in the linear range. All HAS assays throughout this work were performed in duplicate and the values were averaged. Table 2 . The cysteine to serine mutation was typically found to be the least altering to protein expression and activity in comparison to substitution with leucine or phenylalanine. The HAS specific activity varied slightly among cysteine to serine mutants except for enzymes containing the C307S mutation. xlHAS1(C307S) and xlHAS1(C307S/C337S) were expressed at levels similar to that of wild type, but xlHAS1(C307S) retained less than 10% of wild type activity while xlHAS1(C307S/C337S) had no detectable HAS activity. The K m values were similar for all mutants except the series with the C337S mutation; UDP-GlcUA binds with lower affinity to these mutants as assessed by higher K m values ( Table 2) . NEM added later will be excluded from the site and the site's modification rate will be decreased. The HAS activity was then determined and compared to the activity of a parallel aliquot of enzyme not treated with NEM. When preincubated with substrates, only xlHAS1(C337S) could be protected from loss of HAS activity due to NEM. The modification of C337 probably inactivates the enzyme by an indirect mechanism because the C337S mutant still retains HAS activity. This mutant enzyme allows analysis of substrate binding characteristics because an "irrelevant" (i.e. non-protectable) inactivation pathway has been eliminated. The UDP-sugar protection effect also required Mg ++ because no protection was observed when 10 mM EDTA chelator was added instead of Mg ++ (data not shown).
RESULTS
Mutant Enzyme Expression and HAS Activity
Loss of HAS Activity Due to NEM Modification
Certain other structurally related compounds also protected xlHAS1(C337S) to various extents from NEM-mediated loss of HAS activity (Table 3 ). The protecting compounds include several UDP-sugars, thymine-containing nucleotides, and several other nucleotide triphosphates.
No nucleotide monophosphate protected the enzyme from NEM-mediated loss of HAS activity (Table 3 and data not shown). The monosaccharides GlcUA and GlcNAc provided little protection ( Table 3 ).
The ability of some molecules to protect xlHAS1(C337S) from NEM-mediated loss of HAS activity allowed for the investigation of the enzyme's apparent affinities for the various compounds. Apparent affinity values were determined by titrating the protectant and measuring the residual HAS activity after NEM treatment. UDP-GlcNAc yielded the highest maximum protection, protecting ~60% of the HAS activity observed in the control not treated with NEM ( Fig. 2A) . UDP-GalNAc, the C4 epimer, protected less than 20% of the control activity, therefore, no apparent affinity value was obtained for this compound. The apparent affinity values for all of the other compounds tested were about 10 -4 M, except for UDP and UTP ( for UDP and UTP. When UDP or UTP were included together with UDP-GlcNAc, an apparent affinity value similar to that of UDP-GlcNAc alone (~10 -4 M) was obtained.
Inhibition of HAS Activity -The protection from NEM-mediated inactivation observed with the added compounds is presumably due to the compounds binding to the enzyme and shielding one or more cysteine residues from NEM modification. This cysteine(s) is hypothesized to be either part of or near a substrate-binding site. To test this assumption of active site occupancy, the compounds were tested for their ability to inhibit HAS activity ( Table 4) . As shown in Table 4 . The K i values were higher when tested under the higher authentic substrate concentration conditions. K m values of xlHAS1 were determined for both substrates in the presence of UMP, UDP, and UDP-Glucose (Table 5) . Although UMP had little effect on the K m values, both UDP and UDP-Glucose raised the values considerably.
There was little effect on V max with any inhibitor. Overall, these alterations in kinetics are the hallmark of competitive inhibition.
DISCUSSION
During the final preparation of this manuscript, it was reported that NEM inactivated HASs from Group A and C Streptococcus (24, 25) . These enzymes contain six and four cysteine residues, respectively. The xlHAS1 polypeptide has 19 cysteines, therefore it is not surprising that this enzyme is sensitive to treatment with NEM. When xlHAS1 is treated with biotinmaleimide, the Western blot band shifts to ~5 kDa larger (data not shown), indicating that there are ~10 free, readily available cysteines. xlHAS1 enzymes containing the C337S mutation were slightly more resistant than wild type enzyme to loss of HAS activity due to NEM, indicating that this residue is responsible in part for the NEM-mediated loss of activity. There are obviously other cysteine residues that are modified by NEM since none of the cysteine to serine mutants or double mutants tested thus far were completely resistant to NEM-mediated loss of HAS activity.
The mutation of C337 to serine caused a large decrease in the enzyme's apparent affinity for UDP-GlcUA (but not UDP-GlcNAc, Table 2 ), suggesting that C337 is somehow involved in the binding of UDP-GlcUA or in GlcUA transfer. This result indicates that C337 is probably close to the substrate-binding or catalytic site. The C337 residue, however, is probably not buried in a substrate pocket or cleft because UDP-sugars could not protect the wild-type enzyme from NEM-mediated inactivation.
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In a recent study on a rat glucosylceramide synthase, it was found that C207 was the primary residue involved in the inactivation by NEM (26) . It has also been recently found that the C226S mutation in the HAS from equisimilis (24) and the C225S mutation in the HAS from pyogenes (25) caused a reduction of about 90% and 50%, respectively, in the HAS activity. Interestingly, based on sequence alignments, these residues roughly correspond to C307 in xlHAS1, which is conserved in all known Class I HASs. As shown in Table 1 , the C307S mutant lost almost all HAS activity. A double mutant with C307S/C337S lost all measurable HAS activity. This finding suggests that C307 plays a role in substrate binding, catalysis, or enzyme folding; the latter explanation may not be as likely due to the mutant xlHAS1 enzyme's proper membrane localization and good expression level.
Even though NEM inactivates the streptococcal HASs, it has been determined that no cysteines are required for enzyme activity in these HASs (24, 25) . Although it was speculated that one or more of these cysteines are located in or near the active sites, the localization of the cysteines to a substrate-binding site was not demonstrated by substrate protection from inactivation. We show here that some of the 19 cysteines in xlHAS1 might be involved in substrate binding or catalysis, based on kinetic and protection data. This involvement might not be direct, but it is clear that loss or modification of some of these cysteines has significant effects on the vertebrate enzyme's ability to function as a HAS.
The fact that xlHAS1 is very specific for the substrates utilized in the HAS reaction could be due to specificity at either the binding step or the catalytic step; our results in this report indicate that the latter is most likely. Table 3 and Figure 3 show that many different compounds are able to bind to the enzyme and protect it from NEM-mediated loss of HAS activity. The protection observed with these non-substrate compounds was usually lower than that observed with the by guest on http://www.jbc.org/ Downloaded from 13 authentic UDP-sugar substrates (Table 3) . One of the most important structural elements appears to be the pyrophosphate moiety because none of the nucleotide monophosphates tested were able to protect the enzyme. It appears that xlHAS1 is able to bind purine-containing nucleotides (eg.
ATP, GDP) as well as many different pyrimidine-containing nucleotide-sugars (eg. UDPglucose). This finding suggests two potential hypotheses: (i) the enzyme can accommodate these different shapes or (ii) the protection seen with these compounds is primarily due to interactions with the phosphate groups. Neither simple phosphate ion nor pyrophosphate ion, however, were able to protect xlHAS1(C337S) from NEM-mediated loss of HAS activity at a concentration of 1 mM (data not shown). This lack of effectiveness could be due to (a) the charge state differences among these various phosphate ions, (b) the smaller size of these compounds (i.e. less sterically hindered of access to pocket or cleft) allowing modification of cysteines that are normally protected by other larger pyrophosphate-containing compounds, and/or (c) a requirement for important interactions with the nucleotide base.
Mg ++ was required for the protection phenomenon, thus it appears that the HAS enzyme binds a UDP-sugar/metal complex. As mentioned earlier, the DXD-containing motif has been implicated in coordination of the divalent metal cation and interaction with the phosphate groups.
All known Class I HASs contain a DXD-containing motif as described by Wiggins and Munro (27) as well as an XDD motif similar to that seen in the putative UDP-sugar transferase SpsA of Bacillus subtilis (7, 8) . When the first aspartate in DXD or the second aspartate in XDD was mutated to glutamate in mouse HAS1, there was a 99% or greater loss of HAS activity (28).
These aspartate residues are probably involved in interactions with Mg ++ and/or the phosphate groups.
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Recently, the crystal structure for SpsA with dTDP has been obtained (8) . This structure shows that SpsA is able to accommodate the methyl group at position 5 of the pyrimidine ring.
Although the substrate specificity or transfer activity of SpsA has yet to be determined, it is obvious that this protein has the ability to bind both dTDP and UDP (7, 8) . Our findings indicate that xlHAS1 can not only accommodate a methyl group at position 5 of the pyrimidine ring, but also a bromine or iodine atom at position 5, or a thiol at position 2. This suggests that there are no intimate or essential interactions between xlHAS1 and positions 2 and 5 of the pyrimidine ring. Interestingly, of the enzymes listed in Table 1 , only half show an interaction with the carbonyl at position 2 of the uridine in the crystal structure. xlHAS1 may interact with the nucleotide base primarily by the hydrophobic effect due to its relatively promiscuous binding of nucleotides, as assessed by the protection data.
When the two structures mentioned above for SpsA with different nucleotides are compared, a shift in the contacts with the ribose ring can be seen to accommodate the loss of the 2' hydroxyl (7, 8) . Since xlHAS1 can not only bind dTDP but also ddTTP, similar shifts are probably made to accommodate the loss of either the 2' hydroxyl or both the 2' and 3' hydroxyls. The proteins shown in Table 1 interact with the ribose hydroxyls but the requirements and importance in catalysis or binding are not known. In the case of xlHAS1, contacts with the ribose hydroxyls may not be essential.
Many of the compounds that provide substantial protection from NEM-mediated loss of HAS activity also appear to be competitive inhibitors of xlHAS1. The K i values of these inhibitors are higher in the presence of increased substrate concentration (Table 4) . UDP and UDP-Glucose alter the K m for the two HAS substrates but do not significantly affect the V max ( The apparent affinity obtained from K m studies is a measure of both the enzyme's ability to bind the substrate as well as its ability to catalyze the addition of the sugar to the growing HA chain. The apparent affinity values for various nucleotides (obtained from Figure 2 ) are measurements of the ability of the enzyme to bind a substrate analog without concern for catalytic ability. The protection from NEM observed with all compounds is probably due to protection of one or more cysteines at a putative substrate-binding site. The UDP-GlcNAc binding site is the most likely candidate because the most protection was observed with this substrate. However, at this stage, it is impossible to determine which particular cysteines are being protected and whether the cysteines participate in catalysis in the putative substratebinding site.
In Figure 3 , dTDP, UDP, and thioUDP show higher inhibition of xlHAS1 in comparison to their protection ability. xlHAS1(C337S) was found to have a much lower apparent affinity for UDP and UTP than for the UDP-sugars (Fig. 2B) . This result could be explained in several ways, including (i) relative steric hindrance, (ii) multisite inhibition, and/or (iii) allosteric regulation. As described below, we believe the first two effects may be responsible, in part, for the observed disparity.
First, it is possible that the lack of sugar moieties on these nucleotides exposes one or more cysteines in a substrate-binding pocket, which are normally protected by UDP-sugars, to modification by NEM. The different levels of maximal protection observed in Figure 2 suggest that there may be variations in the number of cysteines protected by the different compounds.
Specifically, it appears that at least one cysteine is protected by the GlcNAc portion of the UDPGlcNAc molecule. This cysteine is not efficiently protected by any of the other compounds, leading to lower maximal protection values observed for all other compounds (Fig. 2) .
Interestingly, UDP-GalNAc gave the lowest maximal protection, indicating that the position of the C4 hydroxyl is probably critical for efficient or high affinity UDP-GlcNAc binding.
A second potential explanation for higher inhibition than protection is that nucleotides without sugar moieties may be able to bind to both putative substrate-binding sites, thus competing with both substrates simultaneously. This competition would explain the difference in UDP-GlcNAc K m values observed with different concentration of UDP-GlcUA with xlHAS1 (Table 2) , streptococcal HASs (29), and mouse HASs (30) . The protection ability of the UDPlike compounds, however, might be due to binding at only one of these sites (probably the UDPGlcNAc site), thus yielding a lower value in our NEM modification experiments.
A third possible explanation for the observation of greater inhibition compared to protection is allosteric regulation; a site distinct from the catalytic sites would modulate polymerization upon binding UDP. HA is extruded out of the cell once it is produced, therefore, it would be difficult for the cell to determine the amount of HA produced directly. However, UDP, the byproduct of the HAS reaction, may serve as a measure of synthesis rate or extent. Thus, the local UDP concentration level near the synthase might serve as an internal indicator of the amount of HA produced. However, the kinetics finding that UDP and UTP act as competitive inhibitors does not support the solely allosteric control hypothesis. The sensitivity of the vertebrate HASs to UDP may be an adequate potential negative feedback loop to control synthesis levels by a competitive mechanism.
No three-dimensional structure for any HAS is available, thus the direct contacts between substrate and enzyme are not known. Our work is the first assessment of the critical elements of UDP-sugars required for binding to any HAS. A flexible xlHAS1 binding pocket probably interacts with the hydrophobic nucleotide base and a metal-complexed pyrophosphate group. 
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The identification of these critical elements of the substrate may allow for the future design of HAS inhibitors to curtail HA polymer production in certain disease states. Based on sequence similarities, it is probable that the streptococcal and vertebrate HASs interact with the same elements. Also, we have made tentative assignments of the roles of two conserved cysteines found in all vertebrate HASs. Further work on the details of the catalytic mechanism should illuminate the nature of sugar transfer specificity. Table 3 Nucleotide Protection of xlHAS1 from NEM Inactivation Without protection under these conditions, ~80-90% of the enzyme is inactivated by the NEM.
The best protectant in all cases is UDP-GlcNAc. At least slight protection is observed for all pyrophosphate-containing nucleotides. 
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